• Ticker

    Advertisement Find a Broker - Visit the DailyFinance Broker Center
DJIA 12,454.83 -74.92 -0.60%
NASDAQ 2,837.53 -1.85 -0.07%
S&P 500 1,317.82 -2.86 -0.22%

$4.38 $0.06 (1.39%)

REAL-TIME: Last trade at

Flamel Technologies S.A. (ADR)

NASDAQ:FLML

Jump to this page for:

Related Resources

Flamel Technologies reports Q1 EPS (19c), one estimate (7c)

5/7/2012 by Theflyonthewall.com

Flamel Technologies Announces Projected Release Date of First Quarter 2012 Results and Conference Call

4/30/2012 by Business Wire

James Flynn reports 17.58% stake in Flamel Technologies

3/15/2012 by Theflyonthewall.com

24/7 Wall St. Closing Bell (NSC, DNDN, EBAY, CELG, DLR, AXAS, AMCX, CATO, E, FF, ROST, TA, CLWT, TWER, AIXG, WGO, JVA, SCHL, FLML, VRS, EGLE, VRNG)

3/15/2012 by 24/7 Wall Street

Flamel Technologies falls 17.9%

3/15/2012 by Theflyonthewall.com

Morning Movers (SCHL, TWER, JVA, EGLE, FLML)

3/15/2012 by 24/7 Wall Street

Flamel Technologies falls 14.9%

3/15/2012 by Theflyonthewall.com

Flamel Technologies acquires Eclat Pharmaceuticals

3/14/2012 by Theflyonthewall.com

Flamel Technologies reports Q4 EPS (8c), one estimate 10c

3/14/2012 by Theflyonthewall.com

Flamel Technologies Announces Fourth Quarter and Year-End 2011 Results

3/14/2012 by Business Wire

Companies reporting After the Market Close on Wednesday, March 14

3/14/2012 by Theflyonthewall.com

Deerfield raises stake in Flamel Technologies to 17.58% from 5.11%

1/4/2012 by Theflyonthewall.com

Flamel Shares Flamed Out: What You Need to Know

12/15/2011 by The Motley Fool

James E. Flynn reports 5.11% stake in Flamel Technologies

12/5/2011 by Theflyonthewall.com

Flamel Technologies reports Q3 EPS 7c vs. consensus (9c)

11/2/2011 by Theflyonthewall.com

Flamel Technologies Announces Profitable Third Quarter Results

11/2/2011 by Business Wire

Flamel Technologies Announces Projected Release Date of Third Quarter Results; Conference Call

10/27/2011 by Marketwire

Flamel Technologies announces multi-year supply agreement with GlaxoSmithKline

10/18/2011 by Theflyonthewall.com

Flamel Technologies Announces Multi-Year Supply Agreement with GlaxoSmithKline for Coreg CR™ Microparticles

10/18/2011 by Business Wire

Flamel Technologies, Eagle Pharma enter into license and development agreement

10/13/2011 by Theflyonthewall.com

Eagle Pharmaceuticals and Flamel Technologies Announce Eagle to License Medusa Technology for Extended-Release of Tigecycline

10/13/2011 by Business Wire

Deerfield Capital reports 5.0% passive stake in Flamel Technologies

8/31/2011 by Theflyonthewall.com

Flamel Technologies reports Q2 EPS (14c) vs. consensus (9c)

7/25/2011 by Theflyonthewall.com

Flamel Technologies Announces Projected Release Date of Second Quarter Results; Conference Call

7/18/2011 by Marketwire

Flamel Technologies, Digna announce multiple product development agreement

6/27/2011 by Theflyonthewall.com

Flamel Technologies: Elie Vannier to continue to serve as non-executive Chairman

6/24/2011 by Theflyonthewall.com

Flamel Technologies reports Q1 EPS (20c) vs. consensus (11c)

5/9/2011 by Theflyonthewall.com

Flamel Technologies Announces Projected Release Date of First Quarter Results; Conference Call

5/2/2011 by Marketwire

Flamel Technologies announces license agreement for Micropump

4/28/2011 by Theflyonthewall.com

Flamel Technologies reports Q4 EPS 11c vs. consensus 5c

3/3/2011 by Theflyonthewall.com

Flamel Technologies Announces Projected Release Date of Fourth Quarter and Annual Results; Conference Call

2/28/2011 by Marketwire

Flamel Technologies March calls active at elevated prices on sharp rally

2/16/2011 by Theflyonthewall.com

Trading European Volatility: The Options Market's Top 8 European Stock Picks

11/23/2010 by The Motley Fool

Flamel Technologies reports Q3 EPS (14c) vs. consensus 0c

11/4/2010 by Theflyonthewall.com

Flamel Technologies Announces Third Quarter Results; Achievement of Second Milestone in Fourth Quarter with Merck Serono

11/4/2010 by Business Wire

Flamel Technologies Announces Projected Release Date of Third Quarter Results; Conference Call

10/29/2010 by Marketwire

Flamel Tech announces clinical milestone with Merck Serono

10/19/2010 by Theflyonthewall.com

Flamel Technologies Achieves Clinical Milestone with Merck Serono on an Extended Release Formulation of Interferon beta-1a

10/19/2010 by Business Wire

Flamel Continues to Add New Projects to Its Pipeline

9/29/2010 by Morningstar

These Stocks Will Bite You

9/15/2010 by The Motley Fool
See More Articles...